Biotech Growth (UK) Probability of Future Stock Price Finishing Under 638.92
BIOG Stock | 808.00 6.00 0.75% |
Biotech |
Biotech Growth Target Price Odds to finish below 638.92
The tendency of Biotech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to drop to 638.92 or more in 90 days |
808.00 | 90 days | 638.92 | near 1 |
Based on a normal probability distribution, the odds of Biotech Growth to drop to 638.92 or more in 90 days from now is near 1 (This The Biotech Growth probability density function shows the probability of Biotech Stock to fall within a particular range of prices over 90 days) . Probability of Biotech Growth price to stay between 638.92 and its current price of 808.0 at the end of the 90-day period is close to 99 .
Assuming the 90 days trading horizon Biotech Growth has a beta of 0.32 suggesting as returns on the market go up, Biotech Growth average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding The Biotech Growth will be expected to be much smaller as well. Additionally The Biotech Growth has an alpha of 0.2331, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biotech Growth Price Density |
Price |
Predictive Modules for Biotech Growth
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotech Growth. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotech Growth Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotech Growth is not an exception. The market had few large corrections towards the Biotech Growth's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold The Biotech Growth, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotech Growth within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.23 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 30.21 | |
Ir | Information ratio | 0.08 |
Biotech Growth Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotech Growth for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotech Growth can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Net Loss for the year was (82.52 M) with profit before overhead, payroll, taxes, and interest of 101.17 M. | |
Biotech Growth generates negative cash flow from operations | |
Latest headline from news.google.com: The Biotech Growth Trust Shares Up 2.1 percent - Time to Buy - MarketBeat |
Biotech Growth Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biotech Stock often depends not only on the future outlook of the current and potential Biotech Growth's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biotech Growth's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 31.5 M | |
Cash And Short Term Investments | 8.5 M |
Biotech Growth Technical Analysis
Biotech Growth's future price can be derived by breaking down and analyzing its technical indicators over time. Biotech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of The Biotech Growth. In general, you should focus on analyzing Biotech Stock price patterns and their correlations with different microeconomic environments and drivers.
Biotech Growth Predictive Forecast Models
Biotech Growth's time-series forecasting models is one of many Biotech Growth's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotech Growth's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biotech Growth
Checking the ongoing alerts about Biotech Growth for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotech Growth help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Net Loss for the year was (82.52 M) with profit before overhead, payroll, taxes, and interest of 101.17 M. | |
Biotech Growth generates negative cash flow from operations | |
Latest headline from news.google.com: The Biotech Growth Trust Shares Up 2.1 percent - Time to Buy - MarketBeat |
Additional Tools for Biotech Stock Analysis
When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.